In a press release from Kerecis ehf. and Matís ohf. sl. On Friday, the companies announced the signing of a framework agreement for research into fish proteins for the treatment of various medical tissue problems in humans.
The research agreement between the companies is for one year but contains an extension clause. Matís is expected to carry out all of Kerecis' protein research at the company's new biotechnology center in Sauðárkrókur and at its research facility in Reykjavík. Matís has extensive experience and expertise related to the production of products from fish proteins and has first-class research and development facilities for such research.
The full press release can be found here.